Advancements in Data-driven Drug Development

This document is a discussion featuring key figures from Phesi and Frost & Sullivan, focusing on the transformative trends in clinical development within the pharmaceutical industry. It outlines the challenges faced by the industry, such as pipeline pressures and the complexities of regulatory requirements, as well as the difficulties in patient recruitment and trial design. Dr. Gen Li, the Founder and President of Phesi, describes how clinical data science and advanced analytics are reshaping clinical trial design and execution. The conversation details specific examples, including the development of digital patient profiles that enhance understanding of patient populations and improve trial design. Additionally, the document highlights the role of artificial intelligence as a tool in clinical data science, emphasizing that its effectiveness relies on the application of existing knowledge. The discussion also touches on the importance of partnerships and the evolving role of clinical data science in addressing the complexities of drug development.